Search results
Results from the WOW.Com Content Network
Baxter’s kidney-care operations generated about $4.5 billion in revenue last year and have more than 23,000 employees. “This transaction is the right step at the right time for Baxter, capping ...
Approximately 4 million people worldwide receive dialysis treatment for chronic kidney disease. 1 Access to this life-sustaining treatment varies across regions, and patients on dialysis often face physical and emotional burdens throughout the therapy process. Empowering patients and care teams, while helping to break down the barriers to ...
(Reuters) -Private equity firm Carlyle Group is in exclusive talks to acquire Baxter International's kidney care spinoff Vantive for more than $4 billion, including debt, a person familiar with ...
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois. [2] The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion (+2% vs 2022), across three business: "Medical Product and Therapies", "Heathcare ...
Gambro is a global medical technology company that manufactures products for dialysis treatment. The company is involved in developing, manufacturing and supplying products and therapies for kidney and liver dialysis, myeloma kidney therapy [clarify], and other extracorporeal therapies for chronic and acute patients.
Spin-off entity Transaction value (in billions USD) Inflation adjusted (in billions 2022 USD) Ref 1 2024 General Electric Company: GE Aerospace, GE Vernova, GE Healthcare: 191 191 [1] 2 2008 Altria Group: Philip Morris International: 108 141 [2] [3] 3 2000 BCE: Nortel: 60 97 [3] 4 2013 Abbott Laboratories: AbbVie: 56 67 [3] 5 2015 eBay: PayPal ...
Baxter sold its BioPharma Solutions business in October for $4.25 billion to investment firms. The new company, Simtra, wants to expand.
US Renal Care This page was last edited on 6 February 2024, at 23:02 (UTC). Text is available under the Creative Commons Attribution-ShareAlike 4.0 License ...